Ackermann Michael 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Aug 6, 2021
Insider Transaction Report
Form 4
Ackermann Michael
Director10% Owner
Transactions
- Sale
Common Stock
2021-08-05$25.00/sh−1,183$29,575→ 1,231,998 total - Sale
Common Stock
2021-08-05$25.00/sh−100$2,501→ 1,231,898 total - Sale
Common Stock
2021-08-05$25.01/sh−100$2,501→ 1,231,798 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021.